Modified GTX as second-line chemotherapy in advanced pancreatic cancer Journal Article


Authors: Dbouk, H.; Ajouz, H.; Shamseddine, A.; Mukherji, D.; O'Reilly, E. M.; Haydar, A.; Kelsen, D.; Naghy, M.; Eloubeidi, M.; Geara, F.; Saltz, L.; Abou-Alfa, G. K.
Article Title: Modified GTX as second-line chemotherapy in advanced pancreatic cancer
Keywords: cancer survival; survival rate; overall survival; clinical feature; drug tolerability; cisplatin; fluorouracil; advanced cancer; diarrhea; drug efficacy; drug safety; risk benefit analysis; note; capecitabine; gemcitabine; paclitaxel; cancer radiotherapy; disease free survival; pancreas cancer; nuclear magnetic resonance imaging; cancer grading; binding affinity; sensitivity analysis; pancreaticoduodenectomy; disease association; metastasis; computer assisted tomography; liver toxicity; multiple cycle treatment; anemia; tumor volume; leukopenia; nausea; vomiting; ca 19-9 antigen; patient assessment; continuous infusion; docetaxel; irinotecan; alanine aminotransferase; aspartate aminotransferase; bilirubin; cause of death; drug mechanism; dosimetry; folinic acid; drug response; pancreas adenocarcinoma; intermethod comparison; binding site; oxaliplatin; thymidylate synthase; fluoropyrimidine; lymphadenopathy; drug protein binding; blood level; medical history; gimeracil plus oteracil potassium plus tegafur
Journal Title: Gastrointestinal Cancer Research
Volume: 6
Issue: 4
ISSN: 1934-7820
Publisher: International Society of Gastrointestinal Oncology  
Date Published: 2013-01-01
Start Page: 115
End Page: 117
Language: English
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 2 December 2013" - "Source: Scopus"
MSK Authors
  1. Leonard B Saltz
    790 Saltz
  2. Ghassan Abou-Alfa
    568 Abou-Alfa
  3. Eileen O'Reilly
    780 O'Reilly
  4. David P Kelsen
    537 Kelsen